Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation

NCT02504177 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02504177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02504177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2015
Completion date
June 30, 2019
Enrollment
433 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation